title: Early signs of liver failure after low-dose interferon alfa-2b for cutaneous melanoma.
authors.forename: Alfred
authors.initials: A
authors.lastname: Ammoury
authors.forename: Fouad
authors.initials: F
authors.lastname: El Sayed
authors.forename: Caroline
authors.initials: C
authors.lastname: Farah
authors.forename: Jacques
authors.initials: J
authors.lastname: Bazex
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017093:Liver Failure / Q000139:chemically induced* / Q000175:diagnosis*; D008545:Melanoma / Q000188:drug therapy*; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins